首页> 外文期刊>Hematology Reports >Successful allogeneic bone marrow transplantation using immunosuppressive conditioning regimen for a patient with red blood cell transfusion-dependent pyruvate kinase deficiency anemia
【24h】

Successful allogeneic bone marrow transplantation using immunosuppressive conditioning regimen for a patient with red blood cell transfusion-dependent pyruvate kinase deficiency anemia

机译:使用红细胞输血依赖性丙酮酸激酶缺乏症患者使用免疫抑制调理方案的成功同种异体骨髓移植

获取原文
           

摘要

Pyruvate kinase deficiency (PKD) is the rare glycolytic enzyme defect causing hemolytic anemia. Treatments are mainly red cell transfusion and/or splenectomy, leading to iron overload. Allogeneic bone marrow transplantation (BMT) is alternatively curative treatment for severe PKD. The intensity of conditioning is often controversial because of higher risk of graft failure and organ damage. Here, we present a transfusion-dependent PKD patient undergoing BMT from an HLA-identical sibling using intensively immunosuppressive conditioning regimen. This report suggests that BMT using immunosuppressive conditioning regimen may be a feasible and effective treatment for patients with severe PKD with iron overload. We suggest the timing of the transplantation at an earlier age in severe PKD predicted from gene mutation is preferred before cumulative damage of transfusion.
机译:丙酮酸激酶缺乏(PKD)是含有溶血性贫血的稀有糖酵解酶缺陷。治疗主要是红细胞输血和/或脾切除,导致铁过载。同种异体骨髓移植(BMT)是严重PKD的疗效治疗。由于接枝衰竭和器官损伤的风险较高,调节强度通常是争议的。在这里,我们使用强烈的免疫抑制调理方案,从HLA相同的兄弟中介绍经历BMT的输血依赖性PKD患者。本报告表明,使用免疫抑制调理方案的BMT可能是对具有铁过载的严重PKD的患者的可行和有效的治疗方法。我们建议在转弹累积损伤之前,优选从基因突变预测的严重PKD中预先发生的移植的时序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号